PMID- 12631593 OWN - NLM STAT- MEDLINE DCOM- 20031003 LR - 20171116 IS - 1078-0432 (Print) IS - 1078-0432 (Linking) VI - 9 IP - 3 DP - 2003 Mar TI - Tumor cyclooxygenase 2-dependent suppression of dendritic cell function. PG - 961-8 AB - Dendritic cells (DCs) serve as professional antigen-presenting cells and are pivotal in the host immune response to tumor antigens. To define the pathways limiting DC function in the tumor microenvironment, we assessed the impact of tumor cyclooxygenase (COX)-2 expression on DC activities. Bone marrow-derived DCs were cultured in either tumor supernatant (TSN) or TSN from COX-2-inhibited tumors. After culture, DCs were pulsed with tumor-specific peptides, and their ability to generate antitumor immune responses was assessed following injection into established murine lung cancer. In vitro, DC phenotype, alloreactivity, antigen processing and presentation, and interleukin (IL)-10 and IL-12 secretion were evaluated. DCs cultured in TSN failed to generate antitumor immune responses and caused immunosuppressive effects that correlated with enhanced tumor growth. However, genetic or pharmacological inhibition of tumor COX-2 expression restored DC function and effective antitumor immune responses. Functional analyses indicated that TSN causes a decrement in DC capacity to (a) process and present antigens, (b) induce alloreactivity, and (c) secrete IL-12. Whereas TSN DCs showed a significant reduction in cell surface expression of CD11c, DEC-205, MHC class I antigen, MHC class II antigen, CD80, and CD86 as well as a reduction in the transporter-associated proteins, transporter associated with antigen processing 1 and 2, the changes in phenotype and function were not evident when DCs were cultured in supernatant from COX-2-inhibited tumors. We conclude that inhibition of tumor COX-2 expression or activity can prevent tumor-induced suppression of DC activities. FAU - Sharma, Sherven AU - Sharma S AD - University of California Los Angeles School of Medicine-Wadsworth Pulmonary Immunology Laboratory, VA Greater Los Angeles Healthcare System, Los Angeles, CA 90073, USA. FAU - Stolina, Marina AU - Stolina M FAU - Yang, Seok-Chul AU - Yang SC FAU - Baratelli, Felicita AU - Baratelli F FAU - Lin, Jeff F AU - Lin JF FAU - Atianzar, Kimberly AU - Atianzar K FAU - Luo, Jie AU - Luo J FAU - Zhu, Li AU - Zhu L FAU - Lin, Ying AU - Lin Y FAU - Huang, Min AU - Huang M FAU - Dohadwala, Mariam AU - Dohadwala M FAU - Batra, Raj K AU - Batra RK FAU - Dubinett, Steven M AU - Dubinett SM LA - eng GR - CA 71818/CA/NCI NIH HHS/United States GR - P50 CA 90388/CA/NCI NIH HHS/United States GR - R01 CA 78654/CA/NCI NIH HHS/United States GR - R01 CA078654-02/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Clin Cancer Res JT - Clinical cancer research : an official journal of the American Association for Cancer Research JID - 9502500 RN - 0 (Antigens, CD) RN - 0 (B7-1 Antigen) RN - 0 (B7-2 Antigen) RN - 0 (Cd86 protein, mouse) RN - 0 (Isoenzymes) RN - 0 (Membrane Glycoproteins) RN - 0 (Oligonucleotides, Antisense) RN - 0 (Peptides) RN - 130068-27-8 (Interleukin-10) RN - 187348-17-0 (Interleukin-12) RN - EC 1.14.99.1 (Cyclooxygenase 2) RN - EC 1.14.99.1 (Prostaglandin-Endoperoxide Synthases) SB - IM MH - Animals MH - Antigens, CD/biosynthesis MH - B7-1 Antigen/biosynthesis MH - B7-2 Antigen MH - Blotting, Western MH - Cyclooxygenase 2 MH - Cytoplasm/metabolism MH - Dendritic Cells/*enzymology MH - Enzyme-Linked Immunosorbent Assay MH - Flow Cytometry MH - Immunohistochemistry MH - Interleukin-10/biosynthesis MH - Interleukin-12/biosynthesis/metabolism MH - Isoenzymes/*metabolism MH - Lung Neoplasms/enzymology MH - Lymphocytes/metabolism MH - Membrane Glycoproteins/biosynthesis MH - Mice MH - Mice, Inbred BALB C MH - Mice, Inbred C57BL MH - Oligonucleotides, Antisense/pharmacology MH - Peptides/chemistry MH - Phenotype MH - Prostaglandin-Endoperoxide Synthases/*metabolism MH - Time Factors MH - Transfection MH - Tumor Cells, Cultured EDAT- 2003/03/13 04:00 MHDA- 2003/10/04 05:00 CRDT- 2003/03/13 04:00 PHST- 2003/03/13 04:00 [pubmed] PHST- 2003/10/04 05:00 [medline] PHST- 2003/03/13 04:00 [entrez] PST - ppublish SO - Clin Cancer Res. 2003 Mar;9(3):961-8.